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Background: Acute heart failure (AHF) is a heterogeneous in aetiology, pathophysiology and presentation. Despite this diversity, clinical 
trials in AHF deal with this syndrome as a single entity, which may be one reason for repeated failures.
methods: EHFS1 screened consecutive deaths and discharges during 2000-2001 in 115 hospitals of Europe. Information on presenting 
symptoms and signs were gathered. Patients were sorted into seven mutually exclusive classes according to presentation. Class 1: HF 
with cardiac arrest/ ventricular arrhythmia; class 2: HF & ACS; class 3: HF and AF with rapid ventricular response; class 4: HF & acute 
breathlessness; class 5: stable HF; class 6: presenting with other symptoms of HF such as worsening peripheral oedema; and class 7: if 
diagnosis of HF is uncertain.
results: Of all 10,701 patients, we found 260 (2%), 560 (5%), 799 (8%), 2,479 (24%), 703 (7%), 1,040 (10%) and 4,691 (45%) patients 
were in classes 1-7 respectively. Patient in class 1 were younger (median age 69 years) and were more often men (65%) when compared 
with the other classes. A past history of myocardial infarction was more prevalent in class 1 (45%) and class 2 (57%) when compared with 
the other classes (23%, 32%, 33%, 35%, 36% respectively). The prevalence of moderate to severe left ventricular systolic dysfunction was 
higher in class 1 (69%) when compared with the other classes (64%, 48%, 54%, 64%, 59%, 41% respectively). 26% died in class 1, 20% 
in class 2, 10% in class 3, 8% in class 4, 6% in class 5 &6 each and 4% in class 7. Compared to those in class 7, the hazard ratio for death 
during the index admission was 4.9 in class 1 (p= <0.001, CI 3.6-6.6),4 in class 2 (p<0.001, CI= 3.24-5.21), 2.2 in class 3 (p<0.001, CI 
1.72-2.99), 2.09 in class 4 (p<0.001, CI 1.70-2.56), 1.44 in class 5 (p=0.04, CI 1.02-2.02) and 1.36 in class 6 (p=0.04, CI 1.02-1.81) .
conclusion:  AHF is complex, with diverse presentations that are associated with very different subsequent prognosis. Attempts to 
investigate the effect of agents in all patients with a diagnosis of AHF may be futile. A more coherent approach of focused and tighter 
patient selection for drug therapy targeted by clinical presentation is more likely to succeed.
